维普期刊资源整合服务平台（V6.5）

262篇 您的检索式：作者名="Terpos"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio 显示文摘	Terpos E Mihou D Srydlo R	2005	Leukemia2005，19，11：	1
2	Interaction between the skeletaland immune systems in cancer: mechanisms and clinical im-plications 显示文摘	Terpos E Dimopoulos MA	2011	Cancer Immunol Immunother2011，60，3：	1
3	Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications显示文摘	Terpos E Dimopoulos M A	2011	Cancer Immunol Immunother2011，60，3：	1
4	Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index显示文摘	Terpos E Szydlo R Apperley JF	2003	Blood2003，102，3：	1
5	Detection of CD55 - and/or CD59- deficient red cell populations in patients with lymphoproliferative syndromes显示文摘	Meletis J Terpos E Samarkos M	2001	Hematol J2001，2，1：	1
6	Myeloma bone disease:pathophysiology and management显示文摘	Terpos E Dimopoulos MA	2005	Ann Oncol2005，16，8：	1
7	Prechemotherapy serum levels ofCDios, transforming growth factor beta2, and vascular endothelialgrowth factor are associated with prognosis io patients with ad-vanced epithelial ovarian cancer treated with cytoreductive surgeryand platinum-based chemotherapy 显示文摘	Bozas G Terpos E Gika D	2010	Int J Gynecol Cancer2010，20，2：	1
8	Lenalidomide: an update on evidence from clinical trials显示文摘	Dimopoulos MA Terpos E	2010	Blood Rev2010，24，1：	1
9	Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents显示文摘	Terpos E Anargyrou K Katodritou E	2012	Int J Cancer2012，130，3：	1
10	Renal impairment in patients with multiple myeloma a consensus statement on behalf of the International Myeloma Working Group显示文摘	Dimopoulos MA Terpos E Chanan Khan A	2010	J Clin Oncol2010，28，33：	1
11	Osteonecrosis of the jaw in cancer after treatment with bisphosphonates:incidence and risk factors显示文摘	Bamias A Kastritis E Bamia C Moulopoulos LA Melakopoulos I Bozas G Koutsoukou V Gika D Anagnostopoulos A Papadimi-triou C Terpos E Dimopoulos MA		0，，：	1
12	Early effects o{ IL-6 re- ceptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis 显示文摘	Terpos E Fragiadaki K Konsta M	2011	Clin Exp Rheumatol2011，29，6：	1
13	Aurora kinases as targets for cancer therapy显示文摘	Mountzios G Terpos E Dimopoulos MA	2008	Cancer Treat Rev2008，34，2：	1
14	Soluble re-ceptor activator of nuclear factor kB ligand-osteo-protegerin ratio predicts survival in multiple myelo-ma :proposal for a novel prognostic index 显示文摘	Terpos E Szydlo R Apperley JF	2003	Blood2003，102，3：	1
15	Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease显示文摘	Kastritis E Terpos E Moulopoulos L	2012	Leukemia2012，27，：	1
16	Significance of mac- rophage inflammatory protein 1 alpha ( MIP - 1 alpha ) in multiple myeloma显示文摘	TERPOS E POLITOU M VINIOU N	2005	Leuk Lymphoma2005，46，12：	1
17	International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma显示文摘	Dimopoulos M Terpos E Comenzo RL	2009	Leukemia2009，23，：	1
18	Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates:evidence of increased risk after treatment with zoledronic acid显示文摘	Dimopoulos MA Kastritis E Anagnostopoulos A Melakopoulos I Gika D Moulopoulos LA Bamia C Terpos E Tsionos K Bamias A		0，，：	1
19	Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration显示文摘	Terpos E Katodritou E Tsiftsakis E		0，，03：	1
20	Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and el crated bone resorption receiving zoledronic acid显示文摘	Lipton A Cook R Saad F Major P Garnero P Terpos E	2008	Cancer2008，113，：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示